James Investment Research’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-74,044
Closed -$1.13M – 513
2020
Q2
$1.13M Sell
74,044
-277
-0.4% -$4.11K 0.11% 145
2020
Q1
$948K Sell
74,321
-10,178
-12% -$182K 0.1% 134
2019
Q4
$2.03M Buy
84,499
+25,633
+44% +$585K 0.14% 136
2019
Q3
$1.24M Buy
58,866
+19,779
+51% +$409K 0.09% 164
2019
Q2
$863K Sell
39,087
-10,314
-21% -$239K 0.06% 191
2019
Q1
$1.17M Sell
49,401
-55,866
-53% -$1.3M 0.08% 186
2018
Q4
$2.34M Sell
105,267
-69,886
-40% -$1.68M 0.15% 132
2018
Q3
$4.56M Buy
175,153
+25,806
+17% +$716K 0.19% 109
2018
Q2
$4.02M Buy
149,347
+94,156
+171% +$2.49M 0.15% 136
2018
Q1
$1.43M Sell
55,191
-13,509
-20% -$369K 0.05% 442
2017
Q4
$1.89M Buy
68,700
+56,925
+483% +$1.51M 0.06% 320
2017
Q3
$264K Sell
11,775
-72,185
-86% -$1.63M 0.01% 523
2017
Q2
$2.23M Buy
+83,960
New +$2.24M 0.07% 193

Other funds holding TBI

James Investment Research's TBI Position: Q3 2020 in Review

James Investment Research sold out of Trueblue (TBI) in Q3 2020, closing a stake of 74,044 shares — an estimated $1.13M sold.

James Investment Research first reported a position in TBI in Q2 2017 and held it in 13 quarters. The position peaked at $4.56M in Q3 2018. 158 funds tracked by Wall St. Rank hold TBI as of Q3 2020.

  • James Investment Research reported no remaining Trueblue position as of Q3 2020 after selling out during the quarter.
  • James Investment Research sold 74,044 Trueblue shares in Q3 2020, an estimated $1.13M.
  • James Investment Research first reported a position in Trueblue in Q2 2017 and held it in 13 quarters.
  • James Investment Research's Trueblue position peaked at $4.56M in Q3 2018.
  • 158 funds tracked by Wall St. Rank held Trueblue as of Q3 2020.

Based on James Investment Research's 13F filing for Q3 2020, filed 23 Oct 2020.